Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Rizzieri DA, Akabani G, Zalutsky MR, Coleman RE, Metzler SD, Bowsher JE, Toaso B, Anderson E, Lagoo A, Clayton S, Pegram CN, Moore JO, Gockerman JP, DeCastro C, Gasparetto C, Chao NJ, Bigner DD.
Rizzieri DA, et al. Among authors: bowsher je.
Blood. 2004 Aug 1;104(3):642-8. doi: 10.1182/blood-2003-12-4264. Epub 2004 Apr 20.
Blood. 2004.
PMID: 15100153
Free article.
Clinical Trial.